What Do Doctors Think About the Telehealth Boom?
As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party telehealth prescribers to get their hands on these medications, a new survey found. One in eight Americans have used a GLP-1, according to data from KFF back in May.
Public awareness of GLP-1 drugs has increased in the past year, with about one-third (32%) of adults now saying they have heard “a lot” about these drugs, up from 19% in July 2023. Most adults who have taken GLP-1 drugs say they took them to treat a chronic condition including diabetes or heart disease (62%), while about four in ten say they took them primarily to lose weight, the KFF survey found.
Researchers estimate that more than 137 million U.S. adults are eligible for semaglutide, mainly for weight loss, diabetes, or cardiovascular prevention, according to study published in JAMA Cardiology.
Excerpted from Fierce Healthcare
